September 30, 2025

Surrogates with Substance: Decoding Soft Tissue Tumors

Following a new CAP review, Jason L. Hornick discusses the strengths – and limitations – of IHC as a stand-in for molecular testing

The Pathologist

September 26, 2025

Prostate Cancer Screening Is Broken – How Do We Fix It?

Changing guidelines and flawed PSA thresholds have left men uncertain, but modern testing can restore confidence

The Pathologist

September 25, 2025

New Rules Aim to Standardize HRD Testing in Cancer Labs

Consensus recommendations standardize homologous recombination deficiency testing for clinical molecular laboratories

The Pathologist

September 24, 2025

Recent Advances in Treating Diffuse Large B-Cell Lymphoma

The disease we now call diffuse large B-cell lymphoma (DLBCL) has gone by the names of reticulum cell sarcoma, diffuse histiocytic lymphoma, and diffuse large cell lymphoma and included both lymphomas...

The ASCO Post

September 23, 2025

Why Men’s Health Depends on Pathology

RCPath urges investment in diagnostics, point-of-care testing, and laboratory integration to detect disease before it becomes deadly

The Pathologist

September 12, 2025

Dual-Mode Optical System Sharpens Skin Cancer Diagnosis

AI-assisted imaging merges structure and chemistry for noninvasive classification of nonmelanoma cancers

The Analytical Scientist

September 10, 2025

New Pipeline Tackles Multiplex Cancer Imaging

Researchers trial a new workflow for multiplex immunostaining that could support cancer diagnostics and research

The Pathologist

September 09, 2025

Can AI and Molecular Testing Outperform Colonoscopy?

Researchers consider the limits of current colorectal cancer screening and the promise of next-generation diagnostics

The Pathologist

September 09, 2025

Multiomics Improves Late-stage Melanoma Survival

How a single-cell proteomics test, run on a standard pathology slide, can reshape treatment decisions

The Pathologist